Recent Quotes (30 days)

You have no recent quotes
chg | %

BTG plc news

   Watch this stock
Showing stories 1 - 10 of about 90   

Articles published

BTG 705.21 +9.21 (1.32%)
price chart
Why Shire PLC, Hikma Pharmaceuticals Plc And BTG plc Could Complement ...
Investor sentiment in the pharmaceutical sector has weakened considerably in recent days after AbbVie decided to ditch its bid for Shire (LSE: SHP) (NASDAQ: SHPG.
Related articles »  
BTG plc Stock Rating Reaffirmed by JPMorgan Chase & Co. (BTG)
JPMorgan Chase & Co. reaffirmed their overweight rating on shares of BTG plc (LON:BTG) in a report issued on Thursday. JPMorgan Chase & Co.
N+1 Singer Reiterates "Sell" Rating for BTG plc (BTG)  Ticker Report
BTG plc Stock Rating Reaffirmed by Deutsche Bank (BTG)  sleekmoney
Related articles »  
BTG plc Price Target Raised to GBX 745 (BTG)
BTG plc (LON:BTG) had its price objective raised by Deutsche Bank from GBX 655 ($10.46) to GBX 745 ($11.90) in a research report released on Tuesday morning.
BTG plc PT Raised to GBX 750 (BTG)  WKRB News
BTG plc Given New GBX 745 Price Target at Deutsche Bank (BTG)  sleekmoney
Related articles »  
Panmure Gordon Reiterates Buy Rating for BTG plc (BTG)
BTG plc logo Panmure Gordon restated their buy rating on shares of BTG plc (LON:BTG) in a report released on Monday.
Investec Boosts BTG plc Price Target to GBX 832 (BTG)  WKRB News
BTG plc Stock Rating Reaffirmed by Panmure Gordon (BTG)  Watch List News (press release)
Related articles »  
BTG plc: BTG reaches settlement regarding CroFab� patent litigation
London, UK, 10 October 2014: BTG plc (LSE: BTG) today announces that it has settled its United States patent infringement complaint against Instituto Bioclon (Bioclon) of Mexico and Rare Disease Therapeutics, Inc. (RDT) of Nashville, Tennessee.
BTG plc Receives "Overweight" Rating from JPMorgan Chase & Co. (BTG)
BTG plc (LON:BTG)'s stock had its �overweight� rating restated by analysts at JPMorgan Chase & Co. in a research report issued to clients and investors on Thursday.
BTG plc's "Sell" Rating Reiterated at N+1 Singer (BTG)  Mideast Time
Related articles »  
BTG plc Stock Rating Reaffirmed by N+1 Singer (BTG)
N+1 Singer reissued their sell rating on shares of BTG plc (LON:BTG) in a research report released on Thursday morning. N+1 Singer currently has a GBX 486 ($7.89) price objective on the stock.
JPMorgan Chase & Co. Reiterates Overweight Rating for BTG plc (BTG)  Mideast Time
Related articles »  
BTG plc Receives Buy Rating from Deutsche Bank (BTG)
BTG plc logo BTG plc (LON:BTG)'s stock had its �buy� rating reaffirmed by investment analysts at Deutsche Bank in a note issued to investors on Friday.
Burberry Group plc Cut to Reduce at AlphaValue (BRBY)  Ticker Report
Investment Analysts' Ratings Reiterations for September, 19th (AIO, AML ...  Mideast Time
Related articles »  
BTG plc: Directorate Change
London, UK, 25 September 2014: BTG plc (LSE: BTG), the specialist healthcare company, today announces that Melanie Lee, PhD, CBE, FMedSci, DSc (Hons), has been appointed as part time Chief Scientific Officer to BTG, effective from 1 November 2014.
BTG plc Price Target Increased to GBX 750 by Analysts at Panmure Gordon (BTG)
BTG plc (LON:BTG) had its price objective hosited by Panmure Gordon from GBX 670 ($10.88) to GBX 750 ($12.18) in a report released on Friday.
Related articles »